Literature DB >> 31785252

Effect of Different Probes and Expertise on the Interpretation Reliability of Point-of-Care Lung Ultrasound.

Clotilde Gomond-Le Goff1, Laura Vivalda1, Silvia Foligno1, Barbara Loi1, Nadya Yousef1, Daniele De Luca2.   

Abstract

BACKGROUND: The effect of different probes and operator experience on the reliability of lung ultrasound (LU) interpretation has not been investigated. We studied the effect of probes and operator experience on the interpretation reliability of LU in critically ill neonates.
METHODS: This was a prospective, blind, cohort study enrolling patients with basic patterns ("B," "severe B," consolidation). Patients were scanned with microlinear (15 MHz; L15), phased-array sectorial (6-12 MHz; S7), and microconvex (8 MHz; C8) probes, in random order. Static images were acquired in high resolution, anonymized, and included in a pictorial database in random sequences. Seventeen clinicians with different LU experience were asked to blindly assess the pictorial database. Interrater agreement and interpretation reliability were analyzed. Subanalyses according to expertise and probe, and multivariate linear regression (including an "expertise × probe" interaction factor), were also performed.
RESULTS: The agreement tends to be lower and more heterogeneous for residents (intraclass correlation coefficient [ICC], 0.82 [95% CI, 0.74-0.9], P < .001; I2, 67%, P = .04) and for fellows (ICC, 0.93 [95% CI, 0.9-0.97], P < .001; I2, 69%, P = .04), especially when using nonlinear probes, compared with senior physicians (ICC, 0.95 [95% CI, 0.93-0.96], P < .001; I2, 0%, P = .433). Area under the curve (AUC) values were high for all probes (L15, 0.96 [95% CI, 0.93-0.99]; C8, 0.91 [95% CI, 0.85-0.98]; S7, 0.86 [95% CI, 0.82-0.91]) and physicians (senior physicians, 0.95 [95% CI, 0.83-0.99]; fellows, 0.95 [95% CI, 0.75-0.99]; residents, 0.86 [95% CI, 0.5-0.99]). Worse reliability and higher heterogeneity were found when the evaluation was performed by residents (AUC, 0.9 [95% CI, 0.85-0.94], P < .01; I2, 93.6%, P < .001) than by fellows (AUC, 0.99 [95% CI, 0.9-0.999], P < .001; I2, 34.3%, P = .09) and/or by senior physicians (AUC, 0.99 [95% CI, 0.9-0.999], P < .001; I2, 18%, P = .236). The "expertise × probe" interaction factor was associated with lower ICC (standardized regression coefficient β, -0.69; P < .0001; adjusted R2, 0.99) and AUC (standardized regression coefficient β, -0.76; P < .0001; adjusted R2, 0.98).
CONCLUSIONS: LU interpretation in neonates shows good interrater agreement and reliability, irrespective of the probe and rater expertise. The use of nonlinear probes by novice operators is associated with the lowest agreement and reliability.
Copyright © 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  agreement; diagnostic accuracy; expertise; lung ultrasound; neonate; probe

Year:  2019        PMID: 31785252     DOI: 10.1016/j.chest.2019.11.013

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  Lung ultrasound score parallels trends in systemic haemodynamics after PDA ligation: a case series.

Authors:  Marilena Savoia; Patrick J McNamara; Annachiara Titolo; Luigi Cattarossi
Journal:  Eur J Pediatr       Date:  2022-03-22       Impact factor: 3.183

2.  The Inter-Rater Reliability of Pediatric Point-of-Care Lung Ultrasound Interpretation in Children With Acute Respiratory Failure.

Authors:  Ryan L DeSanti; Eileen A Cowan; Pierre D Kory; Michael R Lasarev; Jessica Schmidt; Awni M Al-Subu
Journal:  J Ultrasound Med       Date:  2021-08-11       Impact factor: 2.754

3.  Lung ultrasound score has better diagnostic ability than NT-proBNP to predict moderate-severe bronchopulmonary dysplasia.

Authors:  Almudena Alonso-Ojembarrena; Paula Méndez-Abad; Paula Alonso-Quintela; Pamela Zafra-Rodríguez; Ignacio Oulego-Erroz; Simón P Lubián-López
Journal:  Eur J Pediatr       Date:  2022-06-01       Impact factor: 3.860

4.  Lung ultrasound predicts the development of bronchopulmonary dysplasia: a prospective observational diagnostic accuracy study.

Authors:  Xiaolei Liu; Xiaoming Lv; Di Jin; Heng Li; Hui Wu
Journal:  Eur J Pediatr       Date:  2021-03-23       Impact factor: 3.183

Review 5.  Modern pulmonary imaging of bronchopulmonary dysplasia.

Authors:  Nara S Higano; J Lauren Ruoss; Jason C Woods
Journal:  J Perinatol       Date:  2021-02-05       Impact factor: 2.521

6.  Lung ultrasound features predict admission to the neonatal intensive care unit in infants with transient neonatal tachypnoea or respiratory distress syndrome born by caesarean section.

Authors:  Antonio Poerio; Silvia Galletti; Michelangelo Baldazzi; Silvia Martini; Alessandra Rollo; Sofia Spinedi; Francesco Raimondi; Maurizio Zompatori; Luigi Corvaglia; Arianna Aceti
Journal:  Eur J Pediatr       Date:  2020-09-19       Impact factor: 3.183

7.  Clinical Impact of Vertical Artifacts Changing with Frequency in Lung Ultrasound.

Authors:  Natalia Buda; Agnieszka Skoczylas; Marcello Demi; Anna Wojteczek; Jolanta Cylwik; Gino Soldati
Journal:  Diagnostics (Basel)       Date:  2021-02-26

8.  Interobserver Agreement of Lung Ultrasound Findings of COVID-19.

Authors:  Andre Kumar; Yingjie Weng; Sally Graglia; Sukyung Chung; Youyou Duanmu; Farhan Lalani; Kavita Gandhi; Viveta Lobo; Trevor Jensen; Jeffrey Nahn; John Kugler
Journal:  J Ultrasound Med       Date:  2021-01-11       Impact factor: 2.754

9.  Lung Ultrasound Findings in Patients Hospitalized With COVID-19.

Authors:  Andre Kumar; Yingjie Weng; Youyou Duanmu; Sally Graglia; Farhan Lalani; Kavita Gandhi; Viveta Lobo; Trevor Jensen; Sukyung Chung; Jeffrey Nahn; John Kugler
Journal:  J Ultrasound Med       Date:  2021-03-05       Impact factor: 2.754

10.  Early surfactant replacement guided by lung ultrasound in preterm newborns with RDS: the ULTRASURF randomised controlled trial.

Authors:  Javier Rodriguez-Fanjul; I Jordan; M Balaguer; A Batista-Muñoz; M Ramon; S Bobillo-Perez
Journal:  Eur J Pediatr       Date:  2020-07-24       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.